PL2709617T3 - Zastosowanie seknidazolu w połączeniu w leczeniu doustnym infekcji w stomatologii - Google Patents

Zastosowanie seknidazolu w połączeniu w leczeniu doustnym infekcji w stomatologii

Info

Publication number: PL2709617T3
Authority: PL; Poland
Prior art keywords: secnidazole; combination; oral treatment; dental infections; dental
Prior art date: 2011-05-16

Application number

PL12728638T

Other languages

English (en)

Inventor

Pierre-Marie Defrance

Original Assignee

Vegefarm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-05-16

Filing date

2012-05-14

Publication date

2016-05-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44352217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2709617(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-05-14 Application filed by Vegefarm filed Critical Vegefarm

2016-05-31 Publication of PL2709617T3 publication Critical patent/PL2709617T3/pl

Links

KPQZUUQMTUIKBP-UHFFFAOYSA-N 1-(2-methyl-5-nitro-1-imidazolyl)-2-propanol Chemical compound CC(O)CN1C(C)=NC=C1[N+]([O-])=O KPQZUUQMTUIKBP-UHFFFAOYSA-N 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
229960004076 secnidazole Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Physiology (AREA)
Nutrition Science (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL12728638T 2011-05-16 2012-05-14 Zastosowanie seknidazolu w połączeniu w leczeniu doustnym infekcji w stomatologii PL2709617T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR1101478A FR2975299B1 (fr)	2011-05-16	2011-05-16	Utilisation du secnidazole dans le traitement des infections dentaires
PCT/FR2012/000192 WO2012156599A1 (fr)	2011-05-16	2012-05-14	Utilisation du secnidazole dans le traitement des infections dentaires
EP12728638.3A EP2709617B1 (fr)	2011-05-16	2012-05-14	Utilisation du secnidazole en combinaison dans le traitement oral des infections dentaires

Publications (1)

Publication Number	Publication Date
PL2709617T3 true PL2709617T3 (pl)	2016-05-31

Family

ID=44352217

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12728638T PL2709617T3 (pl)	2011-05-16	2012-05-14	Zastosowanie seknidazolu w połączeniu w leczeniu doustnym infekcji w stomatologii

Country Status (15)

Country	Link
US (1)	US9700574B2 (pl)
EP (1)	EP2709617B1 (pl)
KR (1)	KR20140056179A (pl)
CN (1)	CN103596565B (pl)
BR (1)	BR112013028872B1 (pl)
CL (1)	CL2013003268A1 (pl)
CO (1)	CO6801770A2 (pl)
ES (1)	ES2562163T3 (pl)
FR (1)	FR2975299B1 (pl)
MX (1)	MX2013013339A (pl)
PH (1)	PH12013502335A1 (pl)
PL (1)	PL2709617T3 (pl)
RU (1)	RU2013150335A (pl)
WO (1)	WO2012156599A1 (pl)
ZA (1)	ZA201308025B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20170052626A (ko)	2014-09-05	2017-05-12	심바이오믹스 세러퓨틱스 엘엘씨	세균질증 치료에 사용하기 위한 세크니다졸
US11253501B2 (en)	2015-06-01	2022-02-22	Lupin Inc.	Secnidazole formulations and use in treating bacterial vaginosis
US12280037B2 (en)	2020-09-22	2025-04-22	Evofem Biosciences, Inc.	Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7691831B2 (en) *	1999-03-17	2010-04-06	Ernest L. Bonner, Jr.	Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
CN1559428A (zh) *	2004-03-11	2005-01-05	金春华	一种含有塞克硝唑的根除幽门螺旋杆菌的复方药物

2011
- 2011-05-16 FR FR1101478A patent/FR2975299B1/fr not_active Expired - Fee Related
2012
- 2012-05-14 KR KR1020137032268A patent/KR20140056179A/ko not_active Ceased
- 2012-05-14 RU RU2013150335/15A patent/RU2013150335A/ru not_active Application Discontinuation
- 2012-05-14 CN CN201280023168.3A patent/CN103596565B/zh not_active Expired - Fee Related
- 2012-05-14 EP EP12728638.3A patent/EP2709617B1/fr active Active
- 2012-05-14 MX MX2013013339A patent/MX2013013339A/es not_active Application Discontinuation
- 2012-05-14 ES ES12728638.3T patent/ES2562163T3/es active Active
- 2012-05-14 PH PH1/2013/502335A patent/PH12013502335A1/en unknown
- 2012-05-14 US US14/115,923 patent/US9700574B2/en not_active Expired - Fee Related
- 2012-05-14 WO PCT/FR2012/000192 patent/WO2012156599A1/fr not_active Ceased
- 2012-05-14 BR BR112013028872A patent/BR112013028872B1/pt not_active IP Right Cessation
- 2012-05-14 PL PL12728638T patent/PL2709617T3/pl unknown
2013
- 2013-10-29 ZA ZA2013/08025A patent/ZA201308025B/en unknown
- 2013-11-07 CO CO13263186A patent/CO6801770A2/es not_active Application Discontinuation
- 2013-11-14 CL CL2013003268A patent/CL2013003268A1/es unknown

Also Published As

Publication number	Publication date
US20140080778A1 (en)	2014-03-20
ES2562163T3 (es)	2016-03-02
RU2013150335A (ru)	2015-06-27
KR20140056179A (ko)	2014-05-09
CN103596565A (zh)	2014-02-19
BR112013028872B1 (pt)	2020-01-28
FR2975299A1 (fr)	2012-11-23
MX2013013339A (es)	2013-12-02
FR2975299B1 (fr)	2013-09-27
PH12013502335A1 (en)	2019-03-22
CO6801770A2 (es)	2013-11-29
EP2709617B1 (fr)	2015-11-25
ZA201308025B (en)	2015-04-29
WO2012156599A1 (fr)	2012-11-22
CN103596565B (zh)	2017-06-20
EP2709617A1 (fr)	2014-03-26
US9700574B2 (en)	2017-07-11
CL2013003268A1 (es)	2014-07-04
BR112013028872A2 (pt)	2017-01-31

Publication	Publication Date	Title
PL2627334T3 (pl)	2015-08-31	Kompozycje do stosowania w leczeniu zakażeń wirusowych
TWI559936B (en)	2016-12-01	Oral care compositions
PT3653223T (pt)	2021-12-06	Dispositivo para a entrega oral de compostos terapêuticos
SG11201401056SA (en)	2014-04-28	Oral care compositions
ZA201404442B (en)	2016-03-30	Oral care compositions
ZA201404436B (en)	2016-03-30	Oral care compositions
GB2515439B (en)	2017-08-23	Vesicular formulations for use in the treatment of reduced mobility
ZA201404190B (en)	2016-10-26	Oral care compositions
ZA201205441B (en)	2016-01-27	Dental strip for administration of oral treatment
ZA201404443B (en)	2016-09-28	Oral care compositions
ZA201404280B (en)	2017-02-22	Oral care compositions
ZA201305285B (en)	2016-07-27	Oral care compositions
HRP20181761T1 (hr)	2018-12-28	Novi pripravak alfentanila za liječenje akutne boli
BR112013003275A2 (pt)	2016-06-14	composição de tratamento oral
GB2515440B (en)	2017-02-08	Vesicular Formulations for use in the treatment of Rosacea
PL2678307T3 (pl)	2018-11-30	Zastosowanie pochodnych poliaminoizoprenylu w leczeniu antybiotykami lub środkami antyseptycznymi
PL2709617T3 (pl)	2016-05-31	Zastosowanie seknidazolu w połączeniu w leczeniu doustnym infekcji w stomatologii
SG11201402930QA (en)	2014-07-30	Oral care compositions
GB201022087D0 (en)	2011-02-02	Dental flosser
EP2671532A4 (en)	2016-01-27	DENTAL UNIT
ZA201309119B (en)	2016-08-31	Oral care compositions
ZA201205085B (en)	2013-03-27	An oral treatment composition
ZA201307932B (en)	2017-11-29	Oral care composition for treating dry mouth
PL394512A1 (pl)	2012-10-22	Srodek stomatologiczny przeznaczony do leczenia endodontycznego oraz sposób jago wytwarzania
GB201208770D0 (en)	2012-07-04	Compounds for use in the treatment of adenovirus infections